Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Synergistic effects of diosmetin with erythromycin against ABC transporter over-expressed methicillin-resistant Staphylococcus aureus (MRSA) RN4220/pUL5054 and inhibition of MRSA pyruvate kinase.

Chan BC, Ip M, Gong H, Lui SL, See RH, Jolivalt C, Fung KP, Leung PC, Reiner NE, Lau CB.

Phytomedicine. 2013 May 15;20(7):611-4. doi: 10.1016/j.phymed.2013.02.007. Epub 2013 Mar 27.

PMID:
23541215
2.

Optimization and structure-activity relationships of a series of potent inhibitors of methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase as novel antimicrobial agents.

Kumar NS, Amandoron EA, Cherkasov A, Finlay BB, Gong H, Jackson L, Kaur S, Lian T, Moreau A, Labrière C, Reiner NE, See RH, Strynadka NC, Thorson L, Wong EW, Worrall L, Zoraghi R, Young RN.

Bioorg Med Chem. 2012 Dec 15;20(24):7069-82. doi: 10.1016/j.bmc.2012.10.002. Epub 2012 Oct 17.

PMID:
23141418
3.

Cheminformatics-driven discovery of selective, nanomolar inhibitors for staphylococcal pyruvate kinase.

Axerio-Cilies P, See RH, Zoraghi R, Worral L, Lian T, Stoynov N, Jiang J, Kaur S, Jackson L, Gong H, Swayze R, Amandoron E, Kumar NS, Moreau A, Hsing M, Strynadka NC, McMaster WR, Finlay BB, Foster LJ, Young RN, Reiner NE, Cherkasov A.

ACS Chem Biol. 2012 Feb 17;7(2):350-9. doi: 10.1021/cb2003576. Epub 2011 Nov 21.

PMID:
22066782
4.

Methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase as a target for bis-indole alkaloids with antibacterial activities.

Zoraghi R, Worrall L, See RH, Strangman W, Popplewell WL, Gong H, Samaai T, Swayze RD, Kaur S, Vuckovic M, Finlay BB, Brunham RC, McMaster WR, Davies-Coleman MT, Strynadka NC, Andersen RJ, Reiner NE.

J Biol Chem. 2011 Dec 30;286(52):44716-25. doi: 10.1074/jbc.M111.289033. Epub 2011 Oct 26.

5.

Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase.

Chan BC, Ip M, Lau CB, Lui SL, Jolivalt C, Ganem-Elbaz C, Litaudon M, Reiner NE, Gong H, See RH, Fung KP, Leung PC.

J Ethnopharmacol. 2011 Sep 1;137(1):767-73. doi: 10.1016/j.jep.2011.06.039. Epub 2011 Jul 1.

PMID:
21782012
6.

Identification of pyruvate kinase in methicillin-resistant Staphylococcus aureus as a novel antimicrobial drug target.

Zoraghi R, See RH, Axerio-Cilies P, Kumar NS, Gong H, Moreau A, Hsing M, Kaur S, Swayze RD, Worrall L, Amandoron E, Lian T, Jackson L, Jiang J, Thorson L, Labriere C, Foster L, Brunham RC, McMaster WR, Finlay BB, Strynadka NC, Cherkasov A, Young RN, Reiner NE.

Antimicrob Agents Chemother. 2011 May;55(5):2042-53. doi: 10.1128/AAC.01250-10. Epub 2011 Feb 28.

7.

Mapping the protein interaction network in methicillin-resistant Staphylococcus aureus.

Cherkasov A, Hsing M, Zoraghi R, Foster LJ, See RH, Stoynov N, Jiang J, Kaur S, Lian T, Jackson L, Gong H, Swayze R, Amandoron E, Hormozdiari F, Dao P, Sahinalp C, Santos-Filho O, Axerio-Cilies P, Byler K, McMaster WR, Brunham RC, Finlay BB, Reiner NE.

J Proteome Res. 2011 Mar 4;10(3):1139-50. doi: 10.1021/pr100918u. Epub 2011 Jan 28.

PMID:
21166474
8.

Functional analysis, overexpression, and kinetic characterization of pyruvate kinase from methicillin-resistant Staphylococcus aureus.

Zoraghi R, See RH, Gong H, Lian T, Swayze R, Finlay BB, Brunham RC, McMaster WR, Reiner NE.

Biochemistry. 2010 Sep 7;49(35):7733-47. doi: 10.1021/bi100780t.

PMID:
20707314
9.

Depressive symptoms in Parkinson disease correlate with impaired global and specific cognitive performance.

Fernandez HH, See RH, Gary MF, Bowers D, Rodriguez RL, Jacobson C 4th, Okun MS.

J Geriatr Psychiatry Neurol. 2009 Dec;22(4):223-7. doi: 10.1177/0891988709335792. Epub 2009 May 8.

PMID:
19429848
10.

Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines.

See RH, Petric M, Lawrence DJ, Mok CP, Rowe T, Zitzow LA, Karunakaran KP, Voss TG, Brunham RC, Gauldie J, Finlay BB, Roper RL.

J Gen Virol. 2008 Sep;89(Pt 9):2136-46. doi: 10.1099/vir.0.2008/001891-0.

PMID:
18753223
11.

Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice: implications for a subunit vaccine.

Zakhartchouk AN, Sharon C, Satkunarajah M, Auperin T, Viswanathan S, Mutwiri G, Petric M, See RH, Brunham RC, Finlay BB, Cameron C, Kelvin DJ, Cochrane A, Rini JM, Babiuk LA.

Vaccine. 2007 Jan 2;25(1):136-43. Epub 2006 Aug 2.

PMID:
16919855
12.

Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.

See RH, Zakhartchouk AN, Petric M, Lawrence DJ, Mok CP, Hogan RJ, Rowe T, Zitzow LA, Karunakaran KP, Hitt MM, Graham FL, Prevec L, Mahony JB, Sharon C, Auperin TC, Rini JM, Tingle AJ, Scheifele DW, Skowronski DM, Patrick DM, Voss TG, Babiuk LA, Gauldie J, Roper RL, Brunham RC, Finlay BB.

J Gen Virol. 2006 Mar;87(Pt 3):641-50.

PMID:
16476986
13.

Rapid response research to emerging infectious diseases: lessons from SARS.

Finlay BB, See RH, Brunham RC.

Nat Rev Microbiol. 2004 Jul;2(7):602-7. Review. No abstract available.

PMID:
15197395
14.

Protein kinase A site-specific phosphorylation regulates ATP-binding cassette A1 (ABCA1)-mediated phospholipid efflux.

See RH, Caday-Malcolm RA, Singaraja RR, Zhou S, Silverston A, Huber MT, Moran J, James ER, Janoo R, Savill JM, Rigot V, Zhang LH, Wang M, Chimini G, Wellington CL, Tafuri SR, Hayden MR.

J Biol Chem. 2002 Nov 1;277(44):41835-42. Epub 2002 Aug 23.

15.

Stimulation of p300-mediated transcription by the kinase MEKK1.

See RH, Calvo D, Shi Y, Kawa H, Luke MP, Yuan Z, Shi Y.

J Biol Chem. 2001 May 11;276(19):16310-7. Epub 2001 Feb 22.

17.

A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1.

Johnstone RW, See RH, Sells SF, Wang J, Muthukkumar S, Englert C, Haber DA, Licht JD, Sugrue SP, Roberts T, Rangnekar VM, Shi Y.

Mol Cell Biol. 1996 Dec;16(12):6945-56.

19.
20.

Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300.

Lee JS, Galvin KM, See RH, Eckner R, Livingston D, Moran E, Shi Y.

Genes Dev. 1995 May 15;9(10):1188-98. Erratum in: Genes Dev 1995 Aug 1;9(15):1948-9.

21.

Functional interactions between YY1 and adenovirus E1A.

Lee JS, See RH, Galvin KM, Wang J, Shi Y.

Nucleic Acids Res. 1995 Mar 25;23(6):925-31.

22.

Improved purification and biologic activities of staphylococcal toxic shock syndrome toxin 1.

Kum WW, Laupland KB, See RH, Chow AW.

J Clin Microbiol. 1993 Oct;31(10):2654-60.

24.

Receptors for toxic shock syndrome toxin-1 and staphylococcal enterotoxin A on human blood monocytes.

See RH, Krystal G, Chow AW.

Can J Microbiol. 1992 Sep;38(9):937-44.

PMID:
1281444
27.

Clastogenic activity in urine of workers occupationally exposed to pesticides.

See RH, Dunn BP, San RH.

Mutat Res. 1990 Jul;241(3):251-9.

PMID:
2366805
29.

Clastogenic activity in urine of individuals with urinary bladder infections.

Rosin MP, See RH, San RH.

Cancer Lett. 1989 Sep 15;47(1-2):99-103.

PMID:
2636038
30.
31.

Microbiology of toxic shock syndrome: overview.

See RH, Chow AW.

Rev Infect Dis. 1989 Jan-Feb;11 Suppl 1:S55-60. Review.

PMID:
2648541

Supplemental Content

Support Center